Clinical Trials on Nephrolithiasis, Uric Acid in Belgium

Total 45 results

Universitaire Ziekenhuizen KU Leuven

Completed

Acid Suppressive Therapy - Review of Appropriateness (ASTRA)

Appropriate Startup of Acid Suppressive Therapy

Belgium
KU Leuven

Active, not recruiting

Acute Effect of Exogenous Ketosis on Sleep Architecture Following Strenuous Exercise

Sleep

Belgium
Erasme University Hospital

Completed

Do Anesthesiologists Follow Guidelines on Perioperative Use of Tranexamic Acid? (Periop_TXA)

Blood Loss, Surgical | Blood Transfusion | Tranexamic Acid

Belgium
KU Leuven

Active, not recruiting

Role of Intermittent Exogenous Ketosis in the Physiological and Muscular Adaptive Response to Endurance Training

Exercise Adaptations

Belgium
Universitair Ziekenhuis Brussel

Unknown

Resolving Bile Reflux by Lanreotide in Patients With Roux-en-Y Gastrojejunostomy

Acid Reflux Esophagitis | Non-acid Reflux Esophagitis

Belgium
KU Leuven

Completed

Determination of the Bioavailability of Short Chain Fatty Acids in Healthy Humans

Short Chain Fatty Acids Bioavailability

Belgium
KU Leuven

Active, not recruiting

Effect of Exogenous Ketosis During Ultra-endurance Exercise

Exercise | Cognitive Function | Ketosis | Skeletal Muscle | Ultra-endurance Running

Belgium
KU Leuven

Recruiting

The Systemic Concentration of Short-Chain Fatty Acids After Delivery in the Small and Large Intestine of Healthy Volunteers (Sistine)

Metabolism | Intestinal Absorption | Systemic Availability | Short-chain Fatty Acids

Belgium
AZ Sint-Lucas Gent

Completed

Virtual Reality for Pain Control During Extracorporeal Shock Wave Lithotripsy: a Prospective, Comparative, Randomized Study at a Single Institution

Stone Ureter | Stone, Kidney

Belgium
Universitair Ziekenhuis Brussel

Recruiting

Lanthanum Carbonate (Fosrenol®) to Reduce Oxalate Excretion in Patients With Secondary Hyperoxaluria and Nephrolithiasis (LaCa)

Nephrolithiasis | Secondary Hyperoxaluria

Belgium
Reneo Pharma Ltd

Completed

A Prospective Study of the Disease Characteristics of Adult Patients With Long Chain Fatty Acid Oxidation Disorders (FORWARD)

Fatty Acid Oxidation Disorder

United States, Spain, France, Austria, Poland, Belgium, Czechia, Denmark, Hungary, Italy, United Kingdom
Brugmann University Hospital

Recruiting

Neutrophil Extracellular Traps (NET's) in Prevalent Kidney Stone

Kidney Stone

Belgium
Agnieszka Pozdzik

Completed

Metabolic Risk Factors and Stones Composition in Adult Kidney Stone Formers

Kidney Stone

Belgium
University Hospital, Ghent

Completed

Uremic Toxins in the Intensive Care Units (ICU): Patients With Lactate Acidosis

Acute Renal Failure

Belgium
Jozef Stefan Institute
KU Leuven; University of Lausanne

Active, not recruiting

Intermittent Exogenous Ketosis (IEK) at High Altitude

Hypoxia | Ketosis

Belgium, Slovenia
Agnieszka Pozdzik

Recruiting

Treatment Optimization and Nephrolithiasis Recurrence Prevention With Interdisciplinary Care

Kidney Stone

Belgium
University Hospital, Ghent
EAU Young Academic Urologists Urolithiasis and Endourology Working Group; European... and other collaborators

Enrolling by invitation

PRedictive Accuracy of Initial Stone Burden Evaluation. (PRAISE)

Nephrolithiasis | Urolithiasis | Ureterolithiasis

Belgium
Universitaire Ziekenhuizen KU Leuven

Unknown

Renal Tubular Acidosis in Incident Renal Transplant Recipients

Renal Transplant Disorder

Belgium
Nutricia Research

Completed

PANDA: PKU Amino Acid Evaluation (PANDA)

Phenylketonuria (PKU)

United Kingdom, Belgium
PTC Therapeutics
Genzyme, a Sanofi Company

Terminated

Ataluren for Nonsense Mutation Methylmalonic Acidemia

Amino Acid Metabolism, Inborn Errors

France, United Kingdom, Italy, Belgium, Germany, Switzerland
Indigo Diabetes NV

Completed

The SHINE Study: Safety of Implant and Preliminary Performance of the SHINE SYSTEM in Diabetic Subjects

Diabetes Mellitus, Type 2 | Diabetes Mellitus | Hypoglycemia | Diabetes Mellitus, Type 1 | Ketoacidosis, Diabetic | Hyperglycaemia (Diabetic)

Belgium, Slovenia, France
Nutricia Research

Completed

SNAP: Study Nutrients in Adult PKU (SNAP)

Phenylketonuria

Spain, Belgium, Denmark
Promethera Therapeutics

Completed

Long-term Safety Follow-up Study of Patients Having Received HepaStem (SAF001)

Urea Cycle Disorders | Crigler Najjar Syndrome

Belgium
University Hospital, Ghent

Completed

Veno-venous Extracorporeal CO2 Removal in ARDS-patients to Treat Respiratory Acidosis

ACUTE RESPIRATORY DISTRESS SYNDROME

Belgium
Alexion

Recruiting

Lysosomal Acid Lipase (LAL) Deficiency Registry (ALX-LALD-501)

Wolman Disease | Cholesterol Ester Storage Disease | Lysosomal Acid Lipase Deficiency | Acid Cholesteryl Ester Hydrolase Deficiency, Type 2 | Acid Lipase Deficiency | LIPA Deficiency | LAL-Deficiency

France, Belgium, United States, Spain, Germany, Greece, Israel, Italy, Slovenia, United Kingdom, Brazil, Canada, Denmark, Australia, Croatia, Czechia, Ireland, Mexico, Netherlands, Poland, Portugal, Saudi Arabia
Laboratoires Genévrier

Completed

Evaluation of Non-cultured Epidermal Cellular Grafting vs Hyaluronic Acid for Repigmenting Vitiligo and Piebaldism

Vitiligo | Piebaldism

Belgium, France, Italy
Swedish Orphan Biovitrum

Completed

Efficacy and Safety of Once Daily Dosing Compared to Twice Daily Dosing of Nitisinone in HT-1 (HT-1)

Hereditary Tyrosinemia, Type I

Belgium, Denmark, France, Germany, Sweden
Promethera Therapeutics

Completed

Study to Evaluate the Efficacy of HepaStem in Urea Cycle Disorders Paediatric Patients (HEP002)

Urea Cycle Disorders

Belgium, Spain, France, Poland
University Hospital, Ghent

Completed

Clinical Study to Determine the Optimal Operation Parameters During CO2 Removal With the Abylcap® System

ARDS (Acute Respiratory Distress Syndrome) | Respiratory Acidosis

Belgium
Arcturus Therapeutics, Inc.

Recruiting

Study for Adolescent and Adult Participants With Ornithine Transcarbamylase Deficiency to Evaluate Safety and Tolerability of ARCT-810

OTC Deficiency | Ornithine Transcarbamylase Deficiency | OTCD

Spain, Belgium, United Kingdom, Sweden
Sangart

Withdrawn

Phase 2c Dose Comparison Study of MP4OX in Trauma

Trauma | Hemorrhagic Shock | Lactic Acidosis

New Zealand, United Kingdom, Israel, France, Switzerland, Australia, Belgium, Brazil, Germany, Norway, South Africa
BioMarin Pharmaceutical

Completed

Kuvan® in Phenylketonuria Patients Less Than 4 Years Old (SPARK)

Phenylketonuria

Italy, Turkey, United Kingdom, Germany, Netherlands, Slovakia, Austria, Belgium, Czechia
EndoStim Inc.

Terminated

An Investigation of the EndoStim® Lower Esophageal Sphincter (LES) Stimulation System for the Treatment of Reflux

Gastroesophageal Reflux | Reflux, Gastroesophageal | Gastroesophageal Reflux Disease (GERD) | Acid Reflux

United States, Belgium, Netherlands, United Kingdom
Alexion Pharmaceuticals

Completed

Safety and Efficacy Study of Sebelipase Alfa in Participants With Lysosomal Acid Lipase Deficiency

Lysosomal Acid Lipase Deficiency

Spain, Germany, Italy, United States, Croatia, Canada, Russian Federation, Denmark, United Kingdom, Belgium, Mexico, Australia, Netherlands, Brazil, Turkey
Centre Hospitalier Universitaire de Liege
Sanofi; Takeda; University of Liege; Orchard Therapeutics; Centre Hospitalier Régional... and other collaborators

Recruiting

Baby Detect : Genomic Newborn Screening

Congenital Adrenal Hyperplasia | Hemophilia A | Hemophilia B | Mucopolysaccharidosis I | Mucopolysaccharidosis II | Cystic Fibrosis | Alpha 1-Antitrypsin Deficiency | Sickle Cell Disease | Fanconi Anemia | Chronic Granulomatous Disease | Wilson Disease | Severe Congenital Neutropenia | Ornithine Transcarbamylase... and other conditions

Belgium
Alnylam Pharmaceuticals

Terminated

A Study to Evaluate Lumasiran in Adults With Recurrent Calcium Oxalate Kidney Stone Disease and Elevated Urinary Oxalate Levels

Recurrent Calcium Oxalate Kidney Stone Disease | Elevated Urinary Oxalate Levels

United States, Italy, Spain, Belgium, Switzerland, United Kingdom
Promethera Therapeutics

Completed

Safety Study of HepaStem for the Treatment of Urea Cycle Disorders (UCD) and Crigler-Najjar Syndrome (CN) (HEP001)

Urea Cycle Disorders | Crigler Najjar Syndrome

Israel, United Kingdom, Belgium, France, Italy
Kaleido Biosciences

Terminated

UNLOCKED: A Phase 2, Open-label Trial With KB195 in Subjects With a Urea Cycle Disorder (UNLOCKED)

Urea Cycle Disorder

Belgium, United States, Spain, United Kingdom, Germany, Switzerland, Turkey
Genzyme, a Sanofi Company

Completed

Safety and Efficacy Evaluation of Repeat neoGAA Dosing in Late Onset Pompe Disease Patients.

Pompe Disease | Glycogen Storage Disease Type II (GSD II) | Acid Maltase Deficiency

United States, Belgium, Denmark, France, Germany, Netherlands, United Kingdom
Tricida, Inc.

Terminated

Evaluation of Effect of TRC101 on Progression of Chronic Kidney Disease in Subjects With Metabolic Acidosis (VALOR-CKD)

Chronic Kidney Disease | Metabolic Acidosis

United States, Albania, Argentina, Armenia, Australia, Belarus, Belgium, Brazil, Bulgaria, Canada, Chile, Colombia, Czechia, France, Georgia, Hong Kong, Hungary, Israel, Italy, Korea, Republic of, Malaysia, Mexico, Netherlands, North... and more
Swedish Orphan Biovitrum

Completed

Long Term Safety Study of Orfadin Treatment in HT-1 Patients in Standard Clinical Care (OPAL)

Hereditary Tyrosinemia, Type I

Belgium, Denmark, France, Germany, Austria, Czechia, Finland, Hungary, Ireland, Italy, Netherlands, Norway, Poland, Portugal, Spain, Sweden, United Kingdom
Genzyme, a Sanofi Company

Recruiting

Pompe Pregnancy Sub-Registry

Pompe Disease (Late-onset) | Glycogen Storage Disease Type II (GSD-II) | Glycogenesis 2 Acid Maltase Deficiency

Croatia, United States, Italy, Belgium, Czechia
Cellaion SA

Terminated

HepaStem Long-Term Safety Registry (PROLONGSTEM)

Urea Cycle Disorder | Crigler-Najjar Syndrome | Acute on Chronic Liver Failure

Belgium, Spain, France, Bulgaria, Poland
Rigshospitalet, Denmark
University College, London

Enrolling by invitation

EuroSIDA - Clinical and Virological Outcome of European Patients Infected With HIV (EuroSIDA)

End Stage Liver Disease | Cardiovascular Diseases | Fractures, Bone | Diabetes Mellitus | Renal Insufficiency | Hepatitis B | Hepatitis C | Kidney Failure, Chronic | Proteinuria | HIV | Coinfection | Acidosis, Lactic | AIDS

Spain, Switzerland, Germany, United Kingdom, Austria, Sweden, Finland, Israel, Denmark, France, Italy, Iceland, Belgium, Slovakia, Norway, Lithuania, Portugal, Poland, Croatia, Czechia, Greece, Hungary, Luxembourg, Argentina, Belarus, Bosnia... and more
Atara Biotherapeutics

Recruiting

A Study to Evaluate Tabelecleucel in Participants With Epstein-barr Virus-associated Diseases

Lymphoproliferative Disorders | Leiomyosarcoma | Stem Cell Transplant Complications | Solid Organ Transplant Complications | Epstein-Barr Virus (EBV)-Associated Diseases | EBV+ Post-transplant Lymphoproliferative Disease (EBV+ PTLD) | Allogeneic Hematopoietic Cell Transplant | EBV+ Sarcomas | EBV+ Lymphoproliferative... and other conditions

United States, Austria, Belgium, France, Italy, Spain, United Kingdom

Clinical Trials on Nephrolithiasis, Uric Acid in Belgium

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in South Africa

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations